FS-1502

· Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FS-1502, covering 2023-09-01 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer. [Phase 1]